Home/Filings/4/0000950170-23-046801
4//SEC Filing

DALESANDRO MARGARET 4

Accession 0000950170-23-046801

CIK 0001836056other

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 5:52 PM ET

Size

6.7 KB

Accession

0000950170-23-046801

Insider Transaction Report

Form 4
Period: 2023-09-01
Transactions
  • Award

    Ordinary Shares

    2023-09-01+125,000125,000 total
  • Award

    Ordinary Shares

    2023-09-01+70,83370,833 total
Footnotes (3)
  • [F1]The Ordinary Shares of the Issuer may be represented by the Issuer's American Depositary Shares ("ADSs"). Each ADS represents seven (7) Ordinary Shares of the Issuer.
  • [F2]Represents the grant of Restricted Stock Units (the "RSUs") payable solely in Ordinary Shares of the Issuer that vest in three successive equal annual installments beginning on September 1, 2024, subject to continuous service through such vesting date.
  • [F3]Represents the grant of RSUs payable solely in Ordinary Shares of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant, and (ii) the day immediately before the next annual general meeting, subject to continuous service through such vesting date.

Documents

1 file

Issuer

Ambrx Biopharma Inc.

CIK 0001836056

Entity typeother

Related Parties

1
  • filerCIK 0001208853

Filing Metadata

Form type
4
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 5:52 PM ET
Size
6.7 KB